Skip to content

ROLE OF BCG VACCINATION AS BOOSTER ON SALMONELLA TYPHI VACCINE

ROLE OF BCG VACCINATION AS BOOSTER ON SALMONELLA TYPHI VACCINE - BCG-TFV1

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON37465
Enrollment
20
Registered
2012-04-17
Start date
2013-07-25
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

efficacy of vaccine vaccination respons

Interventions

None listed

Sponsors

Universitair Medisch Centrum Sint Radboud
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healthy medical students who are scheduled to go on clinical rotation in developing countries and need to be vaccinated with BCG and typhoid fever vaccine

Exclusion criteria

Exclusion criteria: Subjects should not come from a Salmonella typhi endemic country and are not allowed to use any medication except oral anticonception drugs.

Design outcomes

Primary

MeasureTime frame
The following parameters are compared between two groups: cytokine production and antibody titers against salmonella typhi Vi antigen on different time points after vaccination.

Secondary

MeasureTime frame
Gene polymorphisms are analyzed and correlated with innate immunity function

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)